Why the study?
The study investigated the effect of COVID-19 on blood pressure during short term follow-up.
Key points are not available for this paper at this time.
Population
153 confirmed COVID-19 patients admitted to Parkhayat Kutahya hospital
Comparison
Post COVID-19 period vs on admission
Design
Retrospective cohort study
Follow-up
31.6 ± 5.0 days on average
May prompt post-COVID BP monitoring; leaves open causality, persistence, and need for prospective trials.
The coronavirus disease 2019 (COVID-19) outbreak remains a major public health challenge worldwide. The present study investigated the effect of COVID-19 on blood pressure (BP) during short term follow-up. A total of 211 consecutive COVID-19 patients who were admitted to Parkhayat Kutahya hospital were retrospectively screened. Information was obtained from the electronic medical records and National health data registry. The study outcome was new onset of hypertension according to the Eight Joint National Committee and European Society of Cardiology Guidelines. Finally, 153 confirmed COVID-19 patients (mean age 46.5 ± 12.7 years) were enrolled. Both systolic (120.9 ± 7.2 vs 126.5 ± 15.0 mmHg, P <.001) and diastolic BP (78.5 ± 4.4 vs 81.8 ± 7.4 mmHg, P <.001) were significantly higher in the post COVID-19 period than on admission. New onset hypertension was observed in 18 patients at the end of 31.6 ± 5.0 days on average (P <.001). These findings suggest that COVID-19 increases systolic and diastolic BP and may cause new onset hypertension.
No takes yet. Share an insight, caveat, or question.
Mahmut Akpek (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: